Literature DB >> 22265947

Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Richard B Kennedy1, Inna G Ovsyannikova, Iana H Haralambieva, Megan M O'Byrne, Robert M Jacobson, V Shane Pankratz, Gregory A Poland.   

Abstract

Measles infection and vaccine response are complex biological processes that involve both viral and host genetic factors. We have previously investigated the influence of genetic polymorphisms on vaccine immune response, including measles vaccines, and have shown that polymorphisms in HLA, cytokine, cytokine receptor, and innate immune response genes are associated with variation in vaccine response but do not account for all of the inter-individual variance seen in vaccinated populations. In the current study we report the findings of a multigenic analysis of measles vaccine immunity, indicating a role for the measles virus receptor CD46, innate pattern-recognition receptors (DDX58, TLR2, 4, 5, 7 and 8) and intracellular signaling intermediates (MAP3K7, NFKBIA), and key antiviral molecules (VISA, OAS2, MX1, PKR) as well as cytokines (IFNA1, IL4, IL6, IL8, IL12B) and cytokine receptor genes (IL2RB, IL6R, IL8RA) in the genetic control of both humoral and cellular immune responses. This multivariate approach provided additional insights into the genetic control of measles vaccine responses over and above the information gained by our previous univariate SNP association analyses. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265947      PMCID: PMC3288471          DOI: 10.1016/j.vaccine.2012.01.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  66 in total

Review 1.  Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.

Authors:  G A Poland; I G Ovsyannikova; R M Jacobson; D I Smith
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

2.  Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; Jenna E Ryan; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

3.  Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.

Authors:  Joke Beuten; Jonathan A L Gelfond; Jennifer L Franke; Korri S Weldon; Analisa C Crandall; Teresa L Johnson-Pais; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

Review 4.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

Authors:  Margherita T Cantorna; Yan Zhu; Monica Froicu; Anja Wittke
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels.

Authors:  David Reich; Nick Patterson; Vijaya Ramesh; Philip L De Jager; Gavin J McDonald; Arti Tandon; Edwin Choy; Donglei Hu; Bani Tamraz; Ludmila Pawlikowska; Christina Wassel-Fyr; Scott Huntsman; Alicja Waliszewska; Elizabeth Rossin; Rongling Li; Melissa Garcia; Alexander Reiner; Robert Ferrell; Steve Cummings; Pui-Yan Kwok; Tamara Harris; Joseph M Zmuda; Elad Ziv
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

6.  Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Julie M Cunningham; Robert A Vierkant; Richard B Kennedy; V Shane Pankratz; Gregory A Poland; Robert M Jacobson
Journal:  J Infect Dis       Date:  2006-11-20       Impact factor: 5.226

7.  Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.

Authors:  Luis Rodríguez-Rodríguez; José Ramón Lamas; Jezabel Varadé; Pedro López-Romero; Pilar Tornero-Esteban; Lydia Abasolo; Emilio Gomez de la Concha; Juan Angel Jover; Elena Urcelay; Benjamín Fernández-Gutiérrez
Journal:  Rheumatol Int       Date:  2010-07-27       Impact factor: 2.631

8.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

9.  Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

10.  Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.

Authors:  N Dhiman; I G Ovsyannikova; R A Vierkant; V S Pankratz; R M Jacobson; G A Poland
Journal:  Tissue Antigens       Date:  2008-09
View more
  18 in total

Review 1.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

2.  Humoral responses to independent vaccinations are correlated in healthy boosted adults.

Authors:  Lori Garman; Amanda J Vineyard; Sherry R Crowe; John B Harley; Christina E Spooner; Limone C Collins; Michael R Nelson; Renata J M Engler; Judith A James
Journal:  Vaccine       Date:  2014-08-17       Impact factor: 3.641

3.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

5.  Reduced immunity to measles in adults with major depressive disorder.

Authors:  Bart N Ford; Robert H Yolken; Faith B Dickerson; T Kent Teague; Michael R Irwin; Martin P Paulus; Jonathan Savitz
Journal:  Psychol Med       Date:  2018-03-19       Impact factor: 7.723

Review 6.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 7.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

Review 8.  The personal touch: strategies toward personalized vaccines and predicting immune responses to them.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Iana H Haralambieva; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

9.  Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; Michael T Zimmermann; Diane E Grill; Daniel J Schaid; Gregory A Poland
Journal:  Hum Genet       Date:  2017-03-13       Impact factor: 5.881

10.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.